Cargando…

COVID-19: Brain Effects

Severe acute respiratory syndrome coronavirus 2, the novel coronavirus responsible for the coronavirus disease (COVID-19), affects the brain. Neurologic and neuropsychiatric symptoms may manifest in the acute and post-acute phases of illness. The vulnerability of the brain with aging further increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Dix, Ebony, Roy, Kamolika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257090/
https://www.ncbi.nlm.nih.gov/pubmed/36396269
http://dx.doi.org/10.1016/j.psc.2022.07.009
_version_ 1784741262444724224
author Dix, Ebony
Roy, Kamolika
author_facet Dix, Ebony
Roy, Kamolika
author_sort Dix, Ebony
collection PubMed
description Severe acute respiratory syndrome coronavirus 2, the novel coronavirus responsible for the coronavirus disease (COVID-19), affects the brain. Neurologic and neuropsychiatric symptoms may manifest in the acute and post-acute phases of illness. The vulnerability of the brain with aging further increases the burden of disease in the elderly, who are at the highest risk of complications and death from COVID-19. The mechanisms underlying the effects of COVID-19 on the brain are not fully known. Emerging evidence vis-à-vis pathogenesis and etiologies of COVID-19 brain effects is promising and may pave the way for future research and development of interventions.
format Online
Article
Text
id pubmed-9257090
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92570902022-07-06 COVID-19: Brain Effects Dix, Ebony Roy, Kamolika Psychiatr Clin North Am Article Severe acute respiratory syndrome coronavirus 2, the novel coronavirus responsible for the coronavirus disease (COVID-19), affects the brain. Neurologic and neuropsychiatric symptoms may manifest in the acute and post-acute phases of illness. The vulnerability of the brain with aging further increases the burden of disease in the elderly, who are at the highest risk of complications and death from COVID-19. The mechanisms underlying the effects of COVID-19 on the brain are not fully known. Emerging evidence vis-à-vis pathogenesis and etiologies of COVID-19 brain effects is promising and may pave the way for future research and development of interventions. Elsevier Inc. 2022-12 2022-07-06 /pmc/articles/PMC9257090/ /pubmed/36396269 http://dx.doi.org/10.1016/j.psc.2022.07.009 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Dix, Ebony
Roy, Kamolika
COVID-19: Brain Effects
title COVID-19: Brain Effects
title_full COVID-19: Brain Effects
title_fullStr COVID-19: Brain Effects
title_full_unstemmed COVID-19: Brain Effects
title_short COVID-19: Brain Effects
title_sort covid-19: brain effects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257090/
https://www.ncbi.nlm.nih.gov/pubmed/36396269
http://dx.doi.org/10.1016/j.psc.2022.07.009
work_keys_str_mv AT dixebony covid19braineffects
AT roykamolika covid19braineffects